Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone

European Journal of Endocrinology

Volumn 147, Issue 5, 2002, Pages 617-624

  Depenbusch, Marlon ^a   von Eckardstein, Sigrid ^a   Simoni, Manuela ^a   Nieschlag, Eberhard ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHORAGON 1500; CHORIONIC GONADOTROPIN; FERTINORM HP 150; FOLLITROPIN; GONADORELIN; GONADORELIN ACETATE; GONAL F 150; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PREDALON 500; PREGNESIN 5000; TESTODERM 15; TESTOSTERONE; TESTOSTERONE ENANTATE;

ADULT; ARTICLE; AZOOSPERMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLITROPIN BLOOD LEVEL; GONADOTROPIN DEFICIENCY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOPITUITARISM; IDIOPATHIC DISEASE; KALLMANN SYNDROME; LUTEINIZING HORMONE BLOOD LEVEL; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEXUAL DEVELOPMENT; SPERMATOGENESIS; SPERMATOZOON COUNT; TESTIS SIZE; TESTOSTERONE BLOOD LEVEL;

EID: 0036854416     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1470617     Document Type: Article

References (39)

1. Behre HM, Nieschlag E, Meschede D & Partsch CJ. Diseases of the hypothalamus and the pituitary gland. In Andrology: Male Reproductive Health and Dysfunction, edn 2, pp 125-142. Eds E Nieschlag & HM Behre. Berlin: Springer-Verlag, 2000.
2. Liu PY, Turner L, Rushford D, McDonald J, Baker GHW, Conway AJ et al. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotropin for induction of spermatogenesis and fertility in gonadotropin-deficient men. Human Reproduction 1999 14 1540-1545.
3. Young J, Couzinet B, Chanson P, Brailly S, Loumaye E & Schaison G. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with aquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. Journal of Clinical Endocrinology and Metabolism 2000 85 3239-3244.
4. Mulligan T, Iranmanesh A & Veldhuis JD. Pulsatile i.v. infusion of recombinant human LH in leuprolide-suppressed men unmasks impoverished Leydig-cell secretory responsiveness to midphysiological LH drive in the ageing male. Journal of Clinical Endocrinology and Metabolism 2001 86 5547-5553.
5. Srinath BR, Wickings EJ, Witting C & Nieschlag E. Active immunization with follicle-stimulating hormone for fertility control: a 4 1/2-year study in male rhesus monkeys. Fertility and Sterility 1983 40 110-117.
6. Mougdal NR, Ravindranath N, Murthy GS, Dighe RR, Aravindan GR & Martin F. Long-term contraceptive efficacy of vaccine of ovine follicle-stimulating hormone in male bonnet monkeys (Macaca radiata). Journal of Reproduction and Fertility 1992 96 91-102.
7. Jeyakumar M, Suresh R, Krishnamurthy HN & Mougdal NR. Changes in testicular function following specific deprivation in the adult male rabbit. Journal of Endocrinology 1995 147 111-120.
8. Suresh R, Medhamurthy R & Mougdal NR. Comparative studies on the effects of specific immunoneutralization of endogenous FSH or LH on testicular germ cell transformations in the adult bonnet monkey (Macaca radiata). American Journal of Reproductive Immunology 1995 34 35-43.
9. Graf KM, Dias JA & Griswold MD. Decreased spermatogenesis as the result of an induced autoimmune reaction directed against the gonadotropin receptors in male rats. Journal of Andrology 1997 18 174-185.
10. Lei ZM, Mishra S, Zou W, Xu B, Foltz M, Li X et al. Targeted disruption of luteinizing hormone/human chorionic gonadotropin receptor gene. Molecular Endocrinology 2001 15 184-200.
11. Johnsen SG. Maintenance of spermatogenesis induced by hMG treatment by means of continuous hCG treatment in hypogonadotropic men. Acta Endocrinologica 1978 89 763-769.
12. Vicari E, Mongioi A, Calogero AE, Moncada ML, Sidoti G, Polosa P et al. Therapy with human chorionic gonadotropin alone induces spermatogenesis in men with isolated hypogonadotropic hypogonadism: long term follow-up. International Journal of Andrology 1992 14 320-329.
13. Nieschlag E, Simoni M, Gromoll J & Weinbauer GF. Role of FSH in the regulation of spermatogenesis: clinical aspects. Clinical Endocrinology 1999 51 139-146.
14. Büchter D, Behre HM, Kliesch S & Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. European Journal of Endocrinology 1998 139 298-303.
15. WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction, edns 1, 2, 3 and 4. Singapore: Press Concern 1980, Cambridge: University Press 1987, 1992 and 1999.
16. Cooper TG, Neuwinger J, Bahrs S & Nieschlag E. Internal quality control of semen analysis. Fertility and Sterility 1992 58 172-178.
17. Cooper TG, Atkinson AD & Nieschlag E. Experience with external quality control in spermatology. Human Reproduction 1999 14 765-769.
18. Behre HM, Yeung CH, Holstein AF, Weinbauer GF, Gassner P & Nieschlag E. Diagnosis of male infertility and hypogonadism. In Andrology: Male Reproductive Health and Dysfunction, edn 2, pp 89-124. Eds E Nieschlag & HM Behre. Berlin: Springer-Verlag, 2000.
19. Behre HM, Kliesch S, Schaedel F & Nieschlag E. Clinical relevance of scrotal and transrectal ultrasonography in andrological patients. International Journal of Andrology 1995 18 (Suppl 2) 27-31.
20. Weinbauer GF & Nieschlag E. The role of testosterone in spermatogenesis. In Testosterone Action: Deficiency, Substitution, edn 2, ch 4, pp 143-168. Eds E Nieschlag & HM Behre. Berlin: Springer-Verlag, 1990.
21. Weinbauer GF & Nieschlag E. The Leydig cell as a target for male contraception. In The Leydig Cell, pp 629-662. Eds AH Payne, MP Hardy & LD Russell. Vienna: Cache River Press, 1996.
22. O'Donnell L, McLachlan RI, Wreford NG, de Kretser DM & Robertson DM. Testosterone withdrawal promotes stage-specific detachment of round spermatids from the rat seminiferous epithelium. Biology of Reproduction 1996 55 895-901.
23. Awoniyi CA, Zirkin BR, Chandrashekar V & Schlaff WD. Exogenously administered testosterone maintains spermatogenesis quantitatively in adult rats actively immunized against gonadotropin-releasing hormone. Endocrinology 1992 130 3283-3288.
24. Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF & Jameson JL. Hypogonadism caused by a single amino acid substitution in the subunit of luteinizing hormone. New England Journal of Medicine 1992 326 179-183.
25. Weinbauer GF, Behre HM, Fingscheidt U & Nieschlag E. Human follicle-stimulating hormone exerts a stimulatory effect on spermatogenesis, testicular size and serum inhibin levels in the gonadotropin releasing hormone antagonist-treated nonhuman primate (Macaca fascicularis), Endocrinology 1991 129 1831-1839.
26. Kumar TR, Wang Y, Lu N & Matzuk MM. Follicle-stimulating hormone is required for ovarian follicle maturation but not male fertility. Nature Genetics 1997 15 201-204.
27. Krishnamurthy H, Danilovich N, Morales CR & Sairam MR. Qualitative and quantitative decline in spermatogenesis of the follicle-stimulating hormone receptor knockout (FORKO) mouse. Biology of Reproduction 2000 62 1146-1159.
28. Moudgal NR, Sairam MR, Krishnamurthy HN, Sridhar S, Krishnamurthy H & Khan H. Immunization of male bonnet monkeys (Macaca radiata) with a recombinant FSH receptor preparation affect testicular function and fertility. Endocrinology 1997 138 3065.
29. Plant TM & Marshall GR. The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocrine Reviews 2001 22 764-786.
30. Lindstedt G, Nyström E, Matthews C, Ernest I, Janson PO & Chatterjee K. Follitropin (FSH) deficiency in an infertile male due to FSHβ gene mutation. A syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations. Clinical Chemistry and Laboratory Medicine 1998 36 663-665.
31. Phillip M, Arbelle JE, Segev Y & Parvari R. Male hypogonadism due to a mutation in the gene for the β-subunit of follicle-stimulating hormone. New England Journal of Medicine 1998 24 1729-1732.
32. Matsumoto AM, Karpas AE & Bremner WJ. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. Journal of Clinical Endocrinology and Metabolism 1986 62 1184-1192.
33. O'Donnell L, Narula A, Balourdos G, Gu YQ, Wreford NG, Robertson DM et al. Impairment of spermatogonial development and spermiation after testosterone-induced gonadotropin suppression in adult monkeys (Macaca fascicularis). Journal of Clinical Endocrinology and Metabolism 2001 86 1814-1822.
34. Kamischke A, Plöger D, Venherm S, von Eckardstein S & Nieschlag E. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasability study for male contraception. Clinical Endocrinology 2000 53 43-52.
35. Robertson DM, Pruysers E, Stephenson T, Pettersson K, Morton S & McLachlan RI. Sensitive LH and FSH assays for monitoring low serum levels in men undergoing steroidal contraception. Clinical Endocrinology 2001 55 331-339.
36. Handelsman DJ, Spaliviero JA, Simpson JM, Allan CM & Singh J. Spermatogenesis without gonadotropins: maintenance has a lower testosterone threshold than initiation. Endocrinology 1999 140 3938-3946.
37. Marshall GR, Jockenhövel F, Lüdecke D & Nieschlag E. Maintenance of complete but quantitatively reduced spermatogenesis in hypophysectomized monkeys by testosterone alone. Acta Endocrinologica 1986 113 424-431.
38. Behre HM, Kliesch S, Lemcke B, von Eckardstein S & Nieschlag E. Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone. Human Reproduction 2001 16 2570-2577.
39. McLachlan RI. The endocrine control of spermatogenesis. Bailliere's Best Practice and Research in Clinical Endocrinology and Metabolism 2000 14 345-362.